Life-sciences companies are making strides in the fields of gene and cell therapies, omics technologies (genomics, transcriptomics, proteomics and metabolomics, etc.), and smart molecules approaches, creating an urgent need for advanced, cost- and time-effective technologies that can parse largeOriginal Article
You may also like
FDA Approves SpringWorks Therapeutics Treatment for...
ADVANCEMENTS IN GLP-1 ANALOG FORMULATION DEVELOPMENT:...
Axplora Announces €50 Million Investment in GLP-1...
Drug Digest: Advances in Small-Molecule Manufacturing
Navigating Drug Development: The Critical Role of...
MMS Acquires Exploristics and Its Flagship Modeling...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.